Pharmacology

Newt Gingrich, The NIH And Antibiotics

Today the New York Times published an op-ed by Newt Gingrich where he calls for doubling the budget for the National Institutes of Health here in the US.  Who can argue with that? ...

Article - David Shlaes - Apr 22 2015 - 11:21am

Malaria Vaccine Candidate RTS,S/AS01 Phase 3 Clinical Trial Results

The first malaria vaccine candidate (RTS,S/AS01) to reach phase 3 clinical testing is partially effective against clinical disease in young African children up to 4 years after vaccination, according to final trial data published in The Lancet. ...

Article - News Staff - Apr 23 2015 - 4:30pm

Experimental Drug Could Aid Frontline Spinal Injury Treatment

Rapid treatment with a new anti-inflammatory called C5aR could have a major impact on recovery from spinal cord injury. University of Queensland School of Biomedical Sciences researchers Dr. Marc Ruitenberg and Ph.D. student Faith Brennan said they made t ...

Article - News Staff - Apr 23 2015 - 9:00am

Antibiotic Shortages Plus Antibiotic Resistance Raise Concerns About Patient Care

Increasingly, the public distrusts science and medicine. Much of the reason has been due to lawsuits, some of it has been due to strange beliefs among wealthy elites in well-defined parts of the United States. Due to popularized concerns about the safety ...

Article - News Staff - Apr 23 2015 - 9:28am

Chilli Peppers May Prevent Liver Damage And Progression

Daily consumption of capsaicin, the active compound of chilli peppers, was found to have beneficial effects on liver damage. The study found capsaicin reduced the activation of hepatic stellate cells (HSCs) in mice models. HSCs are the major cell type inv ...

Article - News Staff - Apr 23 2015 - 8:24am

New Life For First-Line Antibiotics

Researchers have identified a single, simple metric to guide antibiotic dosing that could bring an entire arsenal of first-line antibiotics back into the fight against drug-resistant pathogens. A computer simulation created by Hannah Meredith, a biomedica ...

Article - News Staff - Apr 26 2015 - 3:00pm

5X: Alarming Rise In Cost Of Multiple Sclerosis Drugs Over 20 Years

A new study shows an "alarming rise" in the costs of drugs used to slow the progression of multiple sclerosis (MS) or reduce the frequency of attacks over the last 20 years. Yet this increase occurred even as there was a substantial increase in ...

Article - News Staff - Apr 27 2015 - 8:16am

Rociletinib For EGFR Lung Cancer: Phase I/II Trial Results

The investigational anti-cancer agent rociletinib (CO-1686) has received the new FDA 'Breakthrough Status' designation, developed to accelerate the approval process for very promising new medical treatments. For a new study, patients were initia ...

Article - News Staff - Apr 30 2015 - 7:22am

AKB-4924 Experimental Drug Boosts Urinary Tract Ability To Fight Infections

Urinary tract infections are common and wide-spread antibiotic resistance has led to calls for new ways to combat these infections. A recent paper details  an experimental drug that stabilizes the human immune defense protein HIF-1α can protect human blad ...

Article - News Staff - May 7 2015 - 4:56pm

Does This Cow Really Exist?

I really need to quit starting all of these things with "just when you think..." because I'm starting to sound like a cliche.  But sometimes, there are just no alternatives. My apologies. Because just when you think things can't get any ...

Article - Josh Bloom - May 3 2015 - 11:51pm